Global Branded Generics Market Size & Outlook, 2021-2030
Global branded generics market, 2018-2030 (US$M)
Related Markets
Global branded generics market highlights
- The global branded generics market generated a revenue of USD 229.1 billion in 2021 and is expected to reach USD 376.0 billion by 2030.
- The market is expected to grow at a CAGR (2022 - 2030) of 5.7% by 2030.
- In terms of segment, anti-hypertensive accounted for a revenue of USD 35.9 billion in 2021.
- Hormones is the most lucrative drug class segment registering the fastest growth during the forecast period.
- In terms of region, Asia Pacific was the largest revenue generating market in 2021.
- Country-wise, France is expected to register the highest CAGR from 2022 to 2030.
Global data book summary
| Market revenue in 2021 | USD 229.1 billion |
| Market revenue in 2030 | USD 376.0 billion |
| Growth rate | 5.7% (CAGR from 2021 to 2030) |
| Largest segment | Anti-hypertensive |
| Fastest growing segment | Hormones |
| Historical data covered | 2018 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2030 |
| Quantitative units | Revenue in USD billion |
| Market segmentation | Alkylating Agents, Antimetabolites, Hormones, Anti-hypertensive, Lipid Lowering drugs, Anti-depressants, Anti-psychotics, Anti-epileptics |
Other key industry trends
- In terms of revenue, the North America accounted for 19.8% of the global branded generics market in 2021.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, France is the fastest growing regional market and is projected to reach USD 6.8 billion by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Branded Generics Market Scope
Branded Generics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global branded generics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to branded generics market will help companies and investors design strategic landscapes.
Anti-hypertensive was the largest segment with a revenue share of 15.67% in 2021. Horizon Databook has segmented the Global branded generics market based on alkylating agents, antimetabolites, hormones, anti-hypertensive, lipid lowering drugs, anti-depressants, anti-psychotics, anti-epileptics covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Branded Generics Drug Class Outlook (Revenue, USD Million, 2018-2030)
- Alkylating Agents
- Antimetabolites
- Hormones
- Anti-hypertensive
- Lipid Lowering drugs
- Anti-depressants
- Anti-psychotics
- Anti-epileptics
- Others
- Global Branded Generics Application Outlook (Revenue, USD Million, 2018-2030)
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Gastrointestinal Diseases
- Dermatological diseases
- Acute and Chronic Pain
- Others
- Global Branded Generics Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Topical
- Oral
- Parenteral
- Others
- Global Branded Generics Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy & Others
Reasons to subscribe to Global branded generics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global branded generics market databook
-
Our clientele includes a mix of branded generics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global branded generics market , including forecasts for subscribers. This global databook contains high-level insights into Global branded generics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global branded generics market size, by regions, 2018-2030 (US$M)
Top 10 countries: Branded generics market size, 2021 (US$M)
Global branded generics market share, by drug class, 2021 & 2030 (%, US$M)
Branded generics market: Opportunity assessment by country
Global branded generics market, by region, 2021 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
